These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 33441063)

  • 1. Deep Learning in the Quest for Compound Nomination for Fighting COVID-19.
    Mernea M; Martin EC; Petrescu AJ; Avram S
    Curr Med Chem; 2021; 28(28):5699-5732. PubMed ID: 33441063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staying Ahead of the Game: How SARS-CoV-2 has Accelerated the Application of Machine Learning in Pandemic Management.
    Williams AH; Zhan CG
    BioDrugs; 2023 Sep; 37(5):649-674. PubMed ID: 37464099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Learning Methods to Predict Mortality in COVID-19 Patients: A Rapid Scoping Review.
    Syed M; Syed S; Sexton K; Greer ML; Zozus M; Bhattacharyya S; Syed F; Prior F
    Stud Health Technol Inform; 2021 May; 281():799-803. PubMed ID: 34042688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning Applications in Drug Repurposing.
    Yang F; Zhang Q; Ji X; Zhang Y; Li W; Peng S; Xue F
    Interdiscip Sci; 2022 Mar; 14(1):15-21. PubMed ID: 35066811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D3AI-CoV: a deep learning platform for predicting drug targets and for virtual screening against COVID-19.
    Yang Y; Zhou D; Zhang X; Shi Y; Han J; Zhou L; Wu L; Ma M; Li J; Peng S; Xu Z; Zhu W
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35443040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence approach fighting COVID-19 with repurposing drugs.
    Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT
    Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug targets for COVID-19 therapeutics: Ongoing global efforts.
    Saxena A
    J Biosci; 2020; 45(1):. PubMed ID: 32661214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A COVID-19 Pandemic Artificial Intelligence-Based System With Deep Learning Forecasting and Automatic Statistical Data Acquisition: Development and Implementation Study.
    Yu CS; Chang SS; Chang TH; Wu JL; Lin YJ; Chien HF; Chen RJ
    J Med Internet Res; 2021 May; 23(5):e27806. PubMed ID: 33900932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian clock modulating small molecules repurposing as inhibitors of SARS-CoV-2 M
    Sultan A; Ali R; Sultan T; Ali S; Khan NJ; Parganiha A
    Chronobiol Int; 2021 Jul; 38(7):971-985. PubMed ID: 33820462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent omics-based computational methods for COVID-19 drug discovery and repurposing.
    Tayara H; Abdelbaky I; To Chong K
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34423353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods.
    Kivrak M; Guldogan E; Colak C
    Comput Methods Programs Biomed; 2021 Apr; 201():105951. PubMed ID: 33513487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins.
    Maffucci I; Contini A
    J Proteome Res; 2020 Nov; 19(11):4637-4648. PubMed ID: 32893632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design.
    Meyer-Almes FJ
    Comput Biol Chem; 2020 Oct; 88():107351. PubMed ID: 32769050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Repurposing of Drugs with Anti-SARS-CoV-2 Activity in Preclinical Trials: A Systematic Review.
    Rocha YM; de Moura GA; de Oliveira JR; de Figueiredo Nicolete LD; Nicolete R
    Curr Med Chem; 2021; 28(22):4577-4585. PubMed ID: 33019921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Learning Based Early Detection Framework for Preliminary Diagnosis of COVID-19 via Onboard Smartphone Sensors.
    Khaloufi H; Abouelmehdi K; Beni-Hssane A; Rustam F; Jurcut AD; Lee E; Ashraf I
    Sensors (Basel); 2021 Oct; 21(20):. PubMed ID: 34696066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug repositioning to combat COVID-19 using artificial intelligence system].
    Shindo N; Toyoshiba H
    Nihon Yakurigaku Zasshi; 2022; 157(1):41-46. PubMed ID: 34980812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review.
    Albahri AS; Hamid RA; Alwan JK; Al-Qays ZT; Zaidan AA; Zaidan BB; Albahri AOS; AlAmoodi AH; Khlaf JM; Almahdi EM; Thabet E; Hadi SM; Mohammed KI; Alsalem MA; Al-Obaidi JR; Madhloom HT
    J Med Syst; 2020 May; 44(7):122. PubMed ID: 32451808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
    Chakraborti S; Bheemireddy S; Srinivasan N
    Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Learning and Medical Image Analysis for COVID-19 Diagnosis and Prediction.
    Liu T; Siegel E; Shen D
    Annu Rev Biomed Eng; 2022 Jun; 24():179-201. PubMed ID: 35316609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.